You just read:

AbbVie's HUMIRA® (Adalimumab) Receives Positive CHMP Opinion to Treat Adult Patients with Active Moderate to Severe Hidradenitis Suppurativa, a Chronic Inflammatory Skin Disease

News provided by

AbbVie

26 Jun, 2015, 12:22 BST